Pancreatic Cancer Research

ResearcherCentre National de la Recherche ScientifiqueActive in the last 2 years

Émilie Mamessier

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-3516-0093; OpenAlex author ID A5052720571. Sources: OpenAlex.

Their work

Papers
10 (first author 1, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
17
Papers, trials and grants by year

2011: 1 paper · 2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: 2 papers · 2017: 2 papers · 2018: 1 paper · 2019: 1 paper · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 10

  1. Macrophages reprogramming driven by cancer-associated fibroblasts under FOLFIRINOX treatment correlates with shorter survival in pancreatic cancer. Co-author DOI 10.1186/s12964-023-01388-7↗
  2. Prognostic impact of tumour-infiltrating lymphocytes and cancer-associated fibroblasts in patients with pancreatic adenocarcinoma of the body and tail undergoi… Co-author DOI 10.1002/bjs.11434↗
  3. XPO1 Expression Is a Poor-Prognosis Marker in Pancreatic Adenocarcinoma. Co-author DOI 10.3390/jcm8050596↗
  4. Molecular classification as prognostic factor and guide for treatment decision of pancreatic cancer. Last author DOI 10.1016/j.bbcan.2018.02.001↗
  5. Prognostic Value of Molecular Subtypes in Pancreatic Cancer. Last author DOI 10.1097/mpa.0000000000000787↗
  6. A 25-gene classifier predicts overall survival in resectable pancreatic cancer. Co-author DOI 10.1186/s12916-017-0936-z↗
  7. Prognostic value of PDL1 expression in pancreatic cancer. Co-author DOI 10.18632/oncotarget.11685↗
  8. Expression of Genes with Copy Number Alterations and Survival of Patients with Pancreatic Adenocarcinoma. Last author PMID 27107061↗
  9. The emerging role of the TGFβ tumor suppressor pathway in pancreatic cancer. First author DOI 10.4161/cc.11.4.19130↗
  10. Genome profiling of pancreatic adenocarcinoma. Co-author DOI 10.1002/gcc.20870↗

Closest collaborators

The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. François Bertucci · 7 shared papers, 2016–2024 · strength 0.69
  2. David Jérémie Birnbaum · 9 shared papers, 2011–2020 · strength 0.66
  3. Daniel Birnbaum · 8 shared papers, 2011–2019 · strength 0.55
  4. Jean‐Luc Raoul · 4 shared papers, 2016–2017 · strength 0.24
  5. Moacyr Jesus Barreto de Melo Rêgo · 1 shared paper, 2024 · strength 0.22
  6. Zainab Hussain · 1 shared paper, 2024 · strength 0.22
  7. Richard Tomasini · 1 shared paper, 2024 · strength 0.22
  8. Jean‐Robert Delpéro · 4 shared papers, 2011–2017 · strength 0.19
  9. Marine Gilabert · 3 shared papers, 2016–2017 · strength 0.19
  10. Olivıer Turrini · 3 shared papers, 2011–2016 · strength 0.13
  11. Théophile Guilbaud · 1 shared paper, 2020 · strength 0.11
  12. Thomas Delayre · 1 shared paper, 2020 · strength 0.11
  13. Max Chaffanet · 2 shared papers, 2011–2016 · strength 0.08
  14. Marc F. Giovannini · 2 shared papers, 2011–2016 · strength 0.08
  15. F. Viret · 1 shared paper, 2011 · strength 0.02
  16. Juan Iovanna · 1 shared paper, 2011 · strength 0.02
  17. Anthony Gonçalvès · 1 shared paper, 2011 · strength 0.02

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.